Latest News

  • RESEARCH

    19 Dec 2025

    A New Twist Makes mRNA Drugs More Selective

  • REGULATORY

    18 Dec 2025

    BARDA Pullback Signals New Phase for US mRNA Development

  • INNOVATION

    17 Dec 2025

    mRNA Design Enters a More Predictive Era

  • INVESTMENT

    15 Dec 2025

    Moderna Bets on Debt to Power mRNA’s Next Act

mRNA Finds a New Role in Personalised Cancer Care

Illustration of syringe targeting virus cell, symbolizing mRNA cancer vaccine research

INNOVATION

12 Dec 2025

Phase 2b melanoma data fuels interest in personalized mRNA vaccines, highlighting design agility while raising new questions about scale, cost, and broader efficacy

Silhouette of a hand holding a syringe in front of BioNTech and Pfizer logos on a bright display background

PARTNERSHIPS

2 Dec 2025

A New mRNA Alliance Tests What Comes After COVID

Pfizer and BioNTech launch a collaborative mRNA R&D initiative that could shape future therapeutic development

Pipette dropping blue liquid into test tubes with DNA strand in background

INVESTMENT

1 Dec 2025

Can A Big Bet On mRNA Reset Biotech’s Pace?

Strand Therapeutics' $153M raise fuels momentum in targeted mRNA therapies and hints at a fast-advancing biotech shift

Syringe drawing dose from medical vial for mRNA vaccine research

PARTNERSHIPS

25 Nov 2025

The Push to Turn mRNA Into a Cancer Weapon

Pfizer and BioNTech deepen mRNA cancer vaccine development as competition grows and FDA signals supportive pathways

Automated production line filling COVID-19 vaccine vials in a sterile facility.

INSIGHTS

24 Nov 2025

Moderna’s Homegrown Bet Could Rewire Biotech’s Future

Moderna boosts US mRNA production, strengthening supply chains as firms like Pfizer explore on shore manufacturing

3D illustration of an mRNA lipid nanoparticle releasing RNA strands into surrounding molecules.

REGULATORY

20 Nov 2025

US MRNA Leaders Push for Regulatory Modernization as Innovation Surges

Moderna, Replicate, and others accelerate mRNA advances as the US faces rising pressure to update its regulatory approach

Technicians working in an mRNA bioprocessing lab with stainless steel bioreactors.

PARTNERSHIPS

18 Nov 2025

New Alliance Aims to Steady the mRNA Supply Chain

Wacker Biotech and RNAV8 Bio join forces to streamline mRNA development and create a more predictable path to the clinic

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.